National drug policies to local formulary decisions in Thailand, China, and Australia: Drug listing changes and opportunities

Yoongthong, Worasuda, Hu, Shanlian, Whitty, Jennifer A. ORCID: https://orcid.org/0000-0002-5886-1933, Wibulpolprasert, Suwit, Sukantho, Kitti, Thienthawee, Wannisa, Han, Huixue and Scuffham, Paul A. (2012) National drug policies to local formulary decisions in Thailand, China, and Australia: Drug listing changes and opportunities. Value in Health, 15 (1). S126-S131. ISSN 1098-3015

Full text not available from this repository. (Request a copy)

Abstract

This commentary is aimed at summarizing the second plenary session presented at the ISPOR 4th Asia-Pacific Conference held in 2010 and compare the issues on drug listing of Thailand, China, and Australia. These countries have substantially different demographic and economic characteristics and health-care financing structures and are in different phases of development of health technology assessment (HTA) (Table 1). Expenditure data shown in Table 1 for 2008 were converted at purchasing power parity to US dollars.

Item Type:	Article
Faculty \ School:	Faculty of Medicine and Health Sciences > Norwich Medical School
UEA Research Groups:	Faculty of Medicine and Health Sciences > Research Groups > Health Economics Faculty of Medicine and Health Sciences > Research Groups > Respiratory and Airways Group Faculty of Medicine and Health Sciences > Research Groups > Health Services and Primary Care Faculty of Medicine and Health Sciences > Research Groups > Public Health and Health Services Research (former - to 2023)
Depositing User:	Pure Connector
Date Deposited:	27 Apr 2016 14:00
Last Modified:	09 Nov 2022 15:31
URI:	https://ueaeprints.uea.ac.uk/id/eprint/58438
DOI:	10.1016/j.jval.2011.11.003

Actions (login required)

View Item